Heterogeneity of treatment effect of interferon-β1b and lopinavir–ritonavir in patients with Middle East respiratory syndrome by cytokine levels

Yaseen M. Arabi(World Health Organization), Naif Khalaf Alharbi(Anna Needs Neuroblastoma Answers), Badriah M. AlMutairi(Anna Needs Neuroblastoma Answers), Ghaleb A. Al Mekhlafi(Riyadh Armed Forces Hospital), Fatehi Elzein(Riyadh Armed Forces Hospital), Ziad A. Memish(Alfaisal University), Ahmad Deeb(King Saud bin Abdulaziz University for Health Sciences), Abdullah M. Assiri(King Khalid University), Frederick G. Hayden(University of Virginia Health System), Haya A. Aljami(King Saud bin Abdulaziz University for Health Sciences), Sarah Al Faraj(King Saud bin Abdulaziz University for Health Sciences), Hanan H. Balkhy(World Health Organization Regional Office for the Eastern Mediterranean), Mashan L. Abdullah(King Saud bin Abdulaziz University for Health Sciences), Yasser Mandourah(Riyadh Armed Forces Hospital), Nisreen Murad Sherbeeni(Riyadh Armed Forces Hospital), Hani Jokhdar(Ministry of Health), Robert Fowler(Sunnybrook Health Science Centre), Ayed Y. Asiri(Prince Mohammed bin Abdulaziz Hospital), Sameera Aljohani, Abdulaziz Al‐Dawood, Sameeh Ghazal(Prince Mohammed bin Abdulaziz Hospital), Shmeylan Al Harbi(King Saud bin Abdulaziz University for Health Sciences), Majed Al Jeraisy(King Saud bin Abdulaziz University for Health Sciences), Jesna Jose(King Saud bin Abdulaziz University for Health Sciences)

Scientific Reports

October 28, 2022

Cited by 3

|Intensive Care Medicine|2021|5.1k

|The Lancet|2020|3.7k

|Critical Care Medicine|2021|2.8k

|The Lancet. Gastroenterology & hepatology|2016|2k

|The Lancet Infectious Diseases|2020|1.8k

Related Papers